Skip to main content
. 2021 Mar 10;27(10):1684–1693. doi: 10.1093/ibd/izab024

TABLE 1.

Table Summarizing Known Drugs That Target Metabolism to Treat IBD

Drug Impact Upon Metabolic Signaling Consequence for Metabolic Pathways
Immunosuppressants (eg, methotrexate) Activates AMPK, blocks mTORC1 Increases OXPHOS
Corticosteroids Blocks mTORC1 Inhibits glycolysis
Aminosalicylates Blocks mTORC1 Inhibits glycolysis
Tacrolimus, everolimus, sirolimus Blocks mTORC1 Inhibits glycolysis